人贩贴:梅斯医学招募高级医学兼职编辑啦!

2016-11-10 MedSci MedSci原创

梅斯医学招募高级医学兼职编辑啦!快来看看吧!边学习边做兼职,一种新鲜一种挑战!招募对象有一定文字撰写能力的医生、医学生、临床医生等工作内容:1,SCI文献指南共识解读;2,根据医学文献或会议内容进行软文撰写;3,专家幻灯整理;职位要求:1,学历、专业:本科以上,临床医学或药学;2,有医院临床工作经验者优先;3,熟悉office办公软件操作,尤其是PPT和Word;4,熟悉医学文章撰写要求,有专业的

梅斯医学招募高级医学兼职编辑啦!快来看看吧!边学习边赚钱,一种新鲜一种挑战!

招募对象

有一定文字撰写能力的医生、医学生

工作内容:

1,SCI文献指南共识解读;

2,根据医学文献或会议内容进行软文撰写;

3,专家幻灯整理;

职位要求:

1,学历、专业:本科以上,临床医学或药学;
2,有医院临床工作经验者优先;
3,熟悉office办公软件操作,尤其是PPT和Word;
4,熟悉医学文章撰写要求,有专业的医学编辑能力;

薪酬:

按件计酬:根据提交的文章质量,按月发放薪酬:100--1000元/篇。

如果你感兴趣,欢迎加入我们!立刻报名:http://wj.qq.com/s/889847/9efb




版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=164977, encodeId=77a11649e7ef, content=请问大三医学生可不可以报呀?, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170123/IMG5885FAB63E3235158.jpg, createdBy=93ef1983852, createdName=1e18c0b6m59(暂无匿称), createdTime=Fri Dec 23 00:14:28 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155169, encodeId=51f5155169db, content=我已经报完, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Nov 12 06:50:05 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276901, encodeId=ee6f12e6901ff, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548506, encodeId=c711154850698, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576991, encodeId=f37115e699191, content=<a href='/topic/show?id=f48630282e9' target=_blank style='color:#2F92EE;'>#兼职#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30282, encryptionId=f48630282e9, topicName=兼职)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=773416357398, createdName=yanjie6253_56072847, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]
    2016-12-23 1e18c0b6m59(暂无匿称)

    请问大三医学生可不可以报呀?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=164977, encodeId=77a11649e7ef, content=请问大三医学生可不可以报呀?, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170123/IMG5885FAB63E3235158.jpg, createdBy=93ef1983852, createdName=1e18c0b6m59(暂无匿称), createdTime=Fri Dec 23 00:14:28 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155169, encodeId=51f5155169db, content=我已经报完, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Nov 12 06:50:05 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276901, encodeId=ee6f12e6901ff, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548506, encodeId=c711154850698, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576991, encodeId=f37115e699191, content=<a href='/topic/show?id=f48630282e9' target=_blank style='color:#2F92EE;'>#兼职#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30282, encryptionId=f48630282e9, topicName=兼职)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=773416357398, createdName=yanjie6253_56072847, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]
    2016-11-12 老段

    我已经报完

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=164977, encodeId=77a11649e7ef, content=请问大三医学生可不可以报呀?, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170123/IMG5885FAB63E3235158.jpg, createdBy=93ef1983852, createdName=1e18c0b6m59(暂无匿称), createdTime=Fri Dec 23 00:14:28 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155169, encodeId=51f5155169db, content=我已经报完, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Nov 12 06:50:05 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276901, encodeId=ee6f12e6901ff, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548506, encodeId=c711154850698, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576991, encodeId=f37115e699191, content=<a href='/topic/show?id=f48630282e9' target=_blank style='color:#2F92EE;'>#兼职#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30282, encryptionId=f48630282e9, topicName=兼职)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=773416357398, createdName=yanjie6253_56072847, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]
    2016-11-12 一闲
  4. [GetPortalCommentsPageByObjectIdResponse(id=164977, encodeId=77a11649e7ef, content=请问大三医学生可不可以报呀?, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170123/IMG5885FAB63E3235158.jpg, createdBy=93ef1983852, createdName=1e18c0b6m59(暂无匿称), createdTime=Fri Dec 23 00:14:28 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155169, encodeId=51f5155169db, content=我已经报完, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Nov 12 06:50:05 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276901, encodeId=ee6f12e6901ff, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548506, encodeId=c711154850698, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576991, encodeId=f37115e699191, content=<a href='/topic/show?id=f48630282e9' target=_blank style='color:#2F92EE;'>#兼职#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30282, encryptionId=f48630282e9, topicName=兼职)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=773416357398, createdName=yanjie6253_56072847, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=164977, encodeId=77a11649e7ef, content=请问大三医学生可不可以报呀?, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170123/IMG5885FAB63E3235158.jpg, createdBy=93ef1983852, createdName=1e18c0b6m59(暂无匿称), createdTime=Fri Dec 23 00:14:28 CST 2016, time=2016-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=155169, encodeId=51f5155169db, content=我已经报完, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sat Nov 12 06:50:05 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276901, encodeId=ee6f12e6901ff, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548506, encodeId=c711154850698, content=<a href='/topic/show?id=6a4756229d9' target=_blank style='color:#2F92EE;'>#招募#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56229, encryptionId=6a4756229d9, topicName=招募)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038c14086626, createdName=ms1260584454294838, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1576991, encodeId=f37115e699191, content=<a href='/topic/show?id=f48630282e9' target=_blank style='color:#2F92EE;'>#兼职#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30282, encryptionId=f48630282e9, topicName=兼职)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=773416357398, createdName=yanjie6253_56072847, createdTime=Sat Nov 12 04:59:00 CST 2016, time=2016-11-12, status=1, ipAttribution=)]

相关资讯

招募患者:Nivolumab注射液治疗晚期或转移性非小细胞肺癌的临床试验

一、题目和背景信息  登记号: CTR20150767  适应症: 晚期或转移性非小细胞肺癌  试验通俗题目: 对复发的晚期或转移性非小细胞肺癌的研究  试验专业

招募患者:PD-1抗体(BMS-936558)在中国晚期或复发性实体瘤受试者中的I、II期、开放性临床研究

1. 试验药物简介 PD-1抗体(programmed death 1)程序性死亡受体1,是一种重要的免疫抑制分子。本试验药物是百时美施贵宝(BMS)研发的Nivolumab。 本试验的适应症是晚期或复发性实体瘤的中国受试者(包括但不限于非小细胞肺癌、胃癌、鼻咽癌、食管癌)。 2. 试验目的 本研究的目的是评估nivolumab治疗中国晚期或复发性实体瘤受试者的安全性和疗

招募女性类风湿关节炎患者参加临床试验

类风湿关节炎是一种以侵蚀性关节炎为主要表现的全身性自身免疫病。本病以女性多发,我国大陆地区的类风关患病率约为0.2%~0.4%。 本病表现为以双手和腕关节等小关节受累为主的对称性、持续性多关节肿胀和疼痛,常伴有晨僵。受累关节以近端指间关节,掌指关节,腕、肘和足趾关节最为多见;同时,颈椎、颞颌关节、胸锁和肩锁关节也可受累。中、晚期的患者可出现手指的“天鹅颈”及“钮

招募患者:西达本胺联合紫杉醇和卡铂治疗晚期非小细胞肺癌的Ⅱ期临床试验

ng: 0px; max-width: 100%; box-sizing: border-box !important; word-wrap: break-word !important;">国家省(州)城市1中国医学科学院肿瘤医院石远凯中国北京北京2天津医科大学附属肿瘤医院李凯中国天津天津3河北医科大学第四医院丁翠敏中国河北石家庄4四川省肿瘤医院余萍中国四川成都5江苏省肿瘤医院冯继峰/史美琪中国

招募兼职福利多多,北京长城会约不约?

第二十六届长城国际心脏病学会议、亚太心脏大会、国际心血管病预防与康复会议2015将于10月29日-11月1日在北京·国家会议中心隆重举行。本次梅斯医学(MedSci)作为官方媒体受邀参加此次大会。是否很想跟小M一起去“逛”长城会,一起参与到盛会中来?现在机会来了!现招募大会兼职5-10名,名额有限,速速来报名丫!工作要求1,善于沟通,灵活,有责任心2,积极配合工作人员,完成任务3,2015年10月